[1]
|
Mathers, C.D. and Loncar, D. (2006) Projections of Global Mortality and Burden of Disease from 2002 to 2030. PLOS Medicine, 3, e442. https://doi.org/10.1371/journal.pmed.0030442
|
[2]
|
Forbes, J.M., Soldatos, G. and Thomas, M.C. (2005) Below the Radar: Advanced Glycation End Products That Detour “Around the Side”. Is HbA1c Not an Accurate Enough Predictor of Long Term Progression and Glycaemic Control in Diabetes? Clinical Biochemist Reviews, 26, 123-134.
|
[3]
|
Katz, R., Wong, N.D., Kronmal, R., et al. (2006) Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation, 113, 2113-2119. https://doi.org/10.1161/CIRCULATIONAHA.105.598086
|
[4]
|
Hegab, Z., Gibbons, S., Neyses, L., et al. (2012) Role of Advanced Glycation End Products in Cardiovascular Disease. World Journal of Cardiology, 4, 90-102. https://doi.org/10.4330/wjc.v4.i4.90
|
[5]
|
Di Pino, A., Currenti, W., Urbano, F., et al. (2017) High Intake of Dietary Advanced Glycation End-Products Is Associated with Increased Arterial Stiffness and Inflammation in Subjects with Type 2 Diabetes. Nutrition, Metabolism and Cardiovascular Diseases, 27, 978-984. https://doi.org/10.1016/j.numecd.2017.06.014
|
[6]
|
Sun, M.Y., Wang, S.J., Li, X.Q., et al. (2019) CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway. Frontiers in Pharmacology, 10, Article 224. https://doi.org/10.3389/fphar.2019.00224
|
[7]
|
Fujita, T., Hemmi, S., Kajiwara, M., et al. (2013) Complement-Mediated Chronic Inflammation Is Associated with Diabetic Microvascular Complication. Diabetes/Metabolism Research and Reviews, 29, 220-226. https://doi.org/10.1002/dmrr.2380
|
[8]
|
Landis, R.C., Quimby, K.R. and Greenidge, A.R. (2018) M1/M2 Macrophages in Diabetic Nephropathy: Nrf2/HO-1 as Therapeutic Targets. Current Pharmaceutical Design, 24, 2241-2249. https://doi.org/10.2174/1381612824666180716163845
|
[9]
|
Nadkarni, G.N., Rao, V., Ismail-Beigi, F., et al. (2016) Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial. Clinical Journal of the American Society of Nephrology, 11, 1343-1352. https://doi.org/10.2215/CJN.12051115
|
[10]
|
Satirapoj, B., Dispan, R., Radinahamed, P., et al. (2018) Urinary Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Predictors for Rapid Loss of Renal Function in Type 2 Diabetic Patients with Diabetic Kidney Disease. BMC Nephrology, 19, Article No. 246. https://doi.org/10.1186/s12882-018-1043-x
|
[11]
|
Lenda, D.M., Kikawada, E., Stanley, E.R., et al. (2003) Reduced Macrophage Recruitment, Proliferation, and Activation in Colony-Stimulating Factor-1-Deficient Mice Results in Decreased Tubular Apoptosis during Renal Inflammation. The Journal of Immunology, 170, 3254-3262. https://doi.org/10.4049/jimmunol.170.6.3254
|
[12]
|
Naito, T., Yokoyama, H., Moore, K.J., et al. (1996) Macrophage Growth Factors Introduced into the Kidney Initiate Renal Injury. Molecular Medicine, 2, 297-312. https://doi.org/10.1007/BF03401628
|
[13]
|
Lim, A.K., Ma, F.Y., Nikolic-Paterson, D.J., et al. (2009) Antibody Blockade of c-fms Suppresses the Progression of Inflammation and Injury in Early Diabetic Nephropathy in Obese db/db Mice. Diabetologia, 52, 1669-1679. https://doi.org/10.1007/s00125-009-1399-3
|
[14]
|
朱志伟, 叶玉燕, 陈丽萍, 等. 糖尿病肾病患者自身免疫及微炎症指标间的相关性和肾功能关系的研究[J]. 中国预防医学杂志, 2020, 21(6): 628-631.
|
[15]
|
Niewczas, M.A., Gohda, T., Skupien, J., et al. (2012) Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes. Journal of the American Society of Nephrology, 23, 507-515. https://doi.org/10.1681/ASN.2011060627
|
[16]
|
Fathy, S.A., Mohamed, M.R., Ali, M.A.M., et al. (2019) Influence of IL-6, IL-10, IFN-γ and TNF-α Genetic Variants on Susceptibility to Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. Biomarkers, 24, 43-45. https://doi.org/10.1080/1354750X.2018.1501761
|
[17]
|
Niewczas, M.A., Pavkov, M.E., Skupien, J., et al. (2019) A Signature of Circulating Inflammatory Proteins and Development of End-Stage Renal Disease in Diabetes. Nature Medicine, 25, 805-813. https://doi.org/10.1038/s41591-019-0415-5
|
[18]
|
彭健韫, 金菊, 项美娟, 等. 血清及尿液生化指标对糖尿病肾病的早期诊断价值分析[J]. 浙江医学, 2022, 44(13): 1397-1401.
|
[19]
|
王洪飞, 郭丽, 林静佳, 等. 同型半胱氨酸、胱抑素C联合超敏C反应蛋白在早期糖尿病肾病诊断中的诊断价值[J]. 中国实验诊断学, 2019, 23(12): 2048-2051.
|
[20]
|
Shikata, K., Okada, S., Matsuda, M., et al. (2003) Intercellular Adhesion Molecule-1-Deficient Mice Are Resistant against Renal Injury after Induction of Diabetes. Diabetes, 52, 2586-2593. https://doi.org/10.2337/diabetes.52.10.2586
|
[21]
|
Ruggenenti, P., Cravedi, P. and Remuzzi, G. (2010) The RAAS in the Pathogenesis and Treatment of Diabetic Nephropathy. Nature Reviews Nephrology, 6, 319-330. https://doi.org/10.1038/nrneph.2010.58
|
[22]
|
Mezzano, S., Droguett, A., Burgos, M.E., et al. (2003) Renin-Angiotensin System Activation and Interstitial Inflammation in Human Diabetic Nephropathy. Kidney International Supplements, 64, S64-S70. https://doi.org/10.1046/j.1523-1755.64.s86.12.x
|
[23]
|
Chen, S.A., Zhang, M.M., Zheng, M., et al. (2020) The Preablation Monocyte/High Density Lipoprotein Ratio Predicts the Late Recurrence of Paroxysmal Atrial Fibrillation after Radiofrequency Ablation. BMC Cardiovascular Disorders, 20, Article No. 401. https://doi.org/10.1186/s12872-020-01670-3
|
[24]
|
Akbas, E.M., Demirtas, L., Ozcicek, A., et al. (2014) Association of Epicardial Adipose Tissue, Neutrophil-to-Lymphocyte Ration and Platelet-to-Lymphocyte Ration with Diabetic Nephropathy. International Journal of Clinical and Experimental Medicine, 7, 1794-1801.
|
[25]
|
黄冉冉, 需英英, 陈矢. 比较中性粒细胞/淋巴细胞、血小板/淋巴细胞和平均血小板体积对早期糖尿病肾病的预测价值[J]. 中华内分泌外科杂志, 2019, 13(1): 76-80.
|
[26]
|
Parthasarathy, S., Barnett, J. and Fong, L.G. (1990) High-Density Lipoprotein Inhibits the Oxidative Modification of Low-Density Lipoprotein. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism, 1044, 275-283. https://doi.org/10.1016/0005-2760(90)90314-N
|
[27]
|
Kanbay, M., Solak, Y., Unal, H.U., et al. (2014) Monocyte Count/HDL Cholesterol Ratio and Cardiovascular Events in Patients with Chronic Kidney Disease. International Urology and Nephrology, 46, 1619-1625. https://doi.org/10.1007/s11255-014-0730-1
|
[28]
|
Poddar, M., Chetty, Y. and Chetty, V.T. (2017) How Does Obesity Affect the Endocrine System? A Narrative Review. Clinical Obesity, 7, 136-144. https://doi.org/10.1111/cob.12184
|
[29]
|
Ulu, S.M., Dogan, M., Ahsen, A., et al. (2013) Neutrophil-to-Lymphocyte Ratio as a Quick and Reliable Predictive Marker to Diagnose the Severity of Diabetic Retinopathy. Diabetes Technology and Therapeutics, 15, 942-947. https://doi.org/10.1089/dia.2013.0097
|
[30]
|
刘光辉, 方萍, 赵家胜. 血小板/淋巴细胞比值和2型糖尿病微血管病变的相关性[J]. 实用医学杂志, 2016, 32(20): 3306-3309.
|
[31]
|
Ganjali, S., Gotto, A.M., Ruscica, M., et al. (2018) Monocyte-to-HDL-Cholesterol Ratio as a Prognostic Marker in Cardiovascular Diseases. Journal Cellular Physiology, 233, 9237-9246. https://doi.org/10.1002/jcp.27028
|
[32]
|
Chen, J.W., Li, C., Liu, Z.H., et al. (2019) The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Prediction of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes. Frontiers in Endocrinology, 10, Article 191. https://doi.org/10.3389/fendo.2019.00191
|
[33]
|
Kurtul, A. and Ornek, E. (2019) Platelet to Lymphocyte Ratio in Cardiovascular Diseases: A Systematic Review. Angiology, 70, 802-818. https://doi.org/10.1177/0003319719845186
|
[34]
|
Efe, F.K. (2021) The Association between Monocyte HDL Ratio and Albuminuria in Diabetic Nephropathy. Pakistan Journal of Medical Sciences, 37, 1128-1132. https://doi.org/10.12669/pjms.37.4.3882
|
[35]
|
Liu, M., Chung, S., Shelness, G.S., et al. (2012) Hepatic ABCA1 and VLDL Triglyceride Production. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 1821, 770-777. https://doi.org/10.1016/j.bbalip.2011.09.020
|
[36]
|
Palazhy, S., Viswanathan, V., et al. (2017) Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy. Diabetes & Metabolism Journal, 41, 128-134. https://doi.org/10.4093/dmj.2017.41.2.128
|
[37]
|
范世珍, 陈旭娜, 于海波. 血清小而密低密度脂蛋白胆固醇对2型糖尿病肾病的早期诊断价值[J]. 中国实验诊断学, 2019, 23(5): 800-803.
|